4.8 Review

Utilization of Treg Cells in Solid Organ Transplantation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Paul N. Harden et al.

Summary: Using autologous polyclonal regulatory T cell therapy in kidney transplantation can reduce immunosuppression dosage, leading to improved long-term clinical outcomes with potentially lower rejection rates compared to standard immunosuppression.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

Alberto Sanchez-Fueyo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Medicine, General & Internal

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial

Andy Roemhild et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Critical Care Medicine

Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients

Jean-Francois Timsit et al.

INTENSIVE CARE MEDICINE (2019)

Review Immunology

Anti-donor regulatory T cell therapy in liver transplantation

Satoru Todo et al.

HUMAN IMMUNOLOGY (2018)

Article Surgery

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

S. Chandran et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

Review Immunology

Development and Maintenance of Regulatory T cells

Naganari Ohkura et al.

IMMUNITY (2013)

Editorial Material Immunology

The molecular mechanisms of regulatory T cell immunosuppression

Kendall A. Smith

FRONTIERS IN IMMUNOLOGY (2012)

Article Gastroenterology & Hepatology

Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion

Vincent Donckier et al.

LIVER TRANSPLANTATION (2006)